BE'ER SHEVA, Israel, Nov. 17, 2015 /PRNewswire/ -- Morphisec today ended its stealth mode with the unveiling of Morphisec Moving Target Defense, a new way for enterprises to defend against targeted and zero-day cyberattacks that exploit application vulnerabilities.
Spearheaded by leading Israeli security experts, Morphisec is offering a powerful and easy-to-use prevention solution that turns the tables on attackers, forcing them to futilely chase after unpredictable moving targets. Morphisec recently closed its Series A round of funding with key investors such as JVP (Jerusalem Venture Partners), GE Ventures and Deutsche Telekom.
Morphisec's game-changing security solution leverages the concept of polymorphism, a technique commonly used by attackers to evade traditional security solutions. In addition to allowing enterprises to block unnoticed attacks, Morphisec's real-time investigation tools accurately and instantaneously identify attack fingerprints – one of its big advantages over existing forensic solutions. IT security managers using Morphisec Moving Target Defense can rest assured their network is protected from unknown (zero-day) and attacks which seek to exploit unpatched application vulnerabilities.
"Patching is one of the biggest headaches for most IT departments. Even more than the time and money patching costs, it creates business disruptions. Hackers know this and take advantage while enterprises become sitting ducks, waiting for the next attack," said Ronen Yehoshua, co-founder and CEO of Morphisec. "For IT and security managers, we are able to give them back the time they need to do their job instead of constantly worrying about patching and the next unknown attack vector. This is a timeless approach to cyber security. There is no worrying about tomorrow, there is no need to dwell on yesterday – we take care of the problem in the moment."
The Morphisec Moving Target Defense solution is comprised of a low footprint, "Install & Forget" endpoint client software – Endpoint Protector. The solution runs on all Windows-based endpoints, physical or virtual, and is sold together with an easy to use central management console. Endpoint Protector can be installed on the fly, does not require a reboot, and does not need any updates of rules, signatures or databases. It provides value for any enterprise concerned with advanced attacks, evasive malware in their network, or a lack of protection due to delayed patching. Morphisec also offers deep forensic and threat intelligence capabilities and services.
"Morphisec has developed a game changing solution that essentially nullifies zero-day attacks. Hackers will no longer be able to attain their objectives for companies having deployed the Morphisec technology," said Stephen Orenberg, Morphisec Advisory Board member and former President of Kaspersky Lab, Inc. "Additionally, Morphisec's forensic exploit and vulnerability analysis ensures that enterprises have their vulnerability patching headache under control and in compliance. These factors, along with zero maintenance requirements and the virtual elimination of false positives, makes Morphisec the solution of choice for corporations seeking to protect their enterprise."
In addition to CEO Ronen Yehoshua, Morphisec is led by Chief Business Officer Omri Dotan, Vice President of R&D Michael Gorelik, Chief Science Officer Mordechai Guri, and Vice President Product Netta Schmeidler. Karel Obluk, former CTO and Chief Scientists at AVG Technologies recently joined as an active board member.
General availability of Morphisec's enterprise product will coincide with RSA Conference 2016 (Q1 2016). Currently Morphisec successfully conducts PoV (proof of value) trials across a variety of industries, including financial services and telecom. To learn more about Morphisec or schedule a demo, contact Morphisec at email@example.com or 617-209-2552.
Emerging from the national cyber security center and from some of the sharpest cyber security minds in Israel, Morphisec offers unique, instantaneous and deterministic prevention of zero-day and known attacks, combined with rich contextualized forensics. Morphisec recently closed its Series A round of funding with key investors such as JVP (Jerusalem Venture Partners), GE Ventures, and Deutsche Telekom. For more info visit www.morphisec.com.
For more information: